Desferal

Active Ingredient(s): Deferoxamine
FDA Approved: * April 1, 1968
Pharm Company: * NOVARTIS
Category: Antidotes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Desferal Overview

Deferoxamine (DFOA), sold under the brand name Desferal, is a medication that binds iron and aluminium.[1] It is specifically used in iron overdose, hemochromatosis either due to multiple blood transfusions or an underlying genetic condition, and aluminium toxicity in people on dialysis.[1][2] It is used by injection into a muscle, vein, or under the skin.[1] Common side effects include pain at the site of injection, diarrhea, vo...

Read more Desferal Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Deferoxamine

Recent Desferal Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Deferoxamine
  • Injection: 2g, 2gm/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Desferal: (2 results)

Sorted by National Drug Code
  • 0078-0347 Desferal 2000 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
  • 0078-0467 Desferal 500 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation

Other drugs which contain Deferoxamine or a similar ingredient: (1 result)

Related Desferal Topics:





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA